Journals / Türkderm Türk deri hastalıkları ve frengi arşivi / 2020 / Cilt: 54 - Sayı: 4

The frequency of epicardial fat pads detected by chest x-rays inpsoriasis patients

Psoriazis hastalarında akciğer grafisi ile tespit edilen epikardiyal yağ yastıkçığı sıklığı

Pages
148–151
Publication Date
2022-11-06
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Prevalence of major CVD risk factors was statistically higher in psoriasis patients (60%, n=142) compared to controls (32%, n=36), (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background and Design: Psoriasis is a chronic inflammatory skin condition associated with several systemic comorbidities including cardiovascular diseases (CVD).
📊
Key Findings & Data:Recent studies revealed epicardial fat thickness, which is also increased in psoriasis, as an early sign of CVD.
💡
Conclusion & Impact:Prevalence of major CVD risk factors was statistically higher in psoriasis patients (60%, n=142) compared to controls (32%, n=36), (p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Background and Design: Psoriasis is a chronic inflammatory skin condition associated with several systemic comorbidities including cardiovascular diseases (CVD). Epicardial fat pad (EFP) is defined as a visceral fat tissue surrounding the heart and coronary vessels. Recent studies revealed epicardial fat thickness, which is also increased in psoriasis, as an early sign of CVD. The aim of this study was to evaluate EFP prevalence and its associations in psoriasis patients.Materials and Methods: Two hundred thirty-seven psoriasis and 113 control patients were assessed for CVD risk factors, Psoriasis Area Severity Index, body composition parameters and laboratory work-up. Controls were chosen from outpatients who lack any chronic inflammatory skin disease and/or systemic inflammatory disease. Evaluation of chest X-rays were performed by a radiologist who was unaware of clinical data.Results: 42.2% of psoriasis patients (n=100) and 31% of controls (n=35) had EFP detected on chest X-ray revealing psoriasis patients had significantly more prevalent EFP than the controls (p=0.047). Prevalence of major CVD risk factors was statistically higher in psoriasis patients (60%, n=142) compared to controls (32%, n=36), (p

Özet

Amaç: Psoriazis, kardiyovasküler hastalıklar (KVH) için bağımsız bir risk faktörü olarak kabul edilmektedir. Epikardiyal yağ yastıkçığı (EYY) isekalp ve koroner damarları çevreleyen visseral yağ dokusu olarak tanımlanmaktadır. Son dönem çalışmalar, psoriazisli hastalarda artış gösterenepikardiyal yağ kalınlığının KVH için erken bir bulgu olduğuna dikkat çekmektedir. Bu çalışmanın amacı, psoriazis hastalarında EYY ve bununlailişkili durumların prevalansını ortaya koymaktır. Gereç ve Yöntem: Bu çalışmada, 237 psoriazis hastası ve 113 kontrol hastası, KVH risk faktörleri, Psoriazis Alan Şiddeti İndeksi, vücutkompozisyon parametreleri ve laboratuvar verileri açısından karşılaştırmalı olarak değerlendirildi. Kontrol grubu kliniğimizde ayaktan hastapolikliniğine başvuran ve hiçbir sistemik enflamatuvar hastalığı olmayan hastalardan seçildi. Akciğer grafileri klinik veriler açısından kör birradyoloji uzmanı tarafından değerlendirildi. Bulgular: Psoriazis hastalarının %42.2’sinde (n=100) ve kontrol grubunun %31’inde (n=35) akciğer grafisinde EYY tespit edildi. Psoriazisgrubunda, EYY sıklığı kontrol grubuna kıyasla istatistiksel anlamlı şekilde yüksekti (p=0,047). Majör KVH risk faktörleri psoriazis hasta grubunda(%60, n=142), kontrol grubuna (%32, n=36) kıyasla istatistiksel olarak anlamlı şekilde yüksek bulundu (p

🔖

Cite This Article

AKPINAR, M. G., ATAKAN, N., DOĞAN, S., ESME, P. (2022). The frequency of epicardial fat pads detected by chest x-rays inpsoriasis patients. Türkderm Türk deri hastalıkları ve frengi arşivi, Cilt: 54 - Sayı: 4, 148–151. https://ajindex.com/articles/622475

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Wang X, Guo Z, Zhu Z, Bao Y, Yang B: Epicardial fat tissue in patients with psoriasis: a systematic review and meta-analysis. Lipids Health Dis 2016;15:103
  2. Lai YC, Yew YW: Psoriasis as an independent risk factor for cardiovascular disease: an epidemiologic analysis using a national database. J Cutan Med Surg 2016;20:327-33
  3. Villasante Fricke AC, Iacobellis G. Epicardial adipose tissue: clinical biomarker of cardio-metabolic risk. Int J Mol Sci 2019;20:5989
  4. Torres T, Bettencourt N, Mendonça D, et al: Epicardial adipose tissue and coronary artery calcification in psoriasis patients. J Eur Acad Dermatol 2015;29:270-7
  5. Raposo I, Torres T: Psoriasis strikes back! Epicardial adipose tissue: Another contributor to the higher cardiovascular risk in psoriasis. Rev Port Cardiol 2015;34:613-6
  6. Bulbul Sen B, Atci N, Rifaioglu E, et al: Increased epicardial fat tissue is a marker of subclinical atherosclerosis in patients with psoriasis. Br J Dermatol 2013;169:1081-6
  7. Doğan S, Menteşoğlu D, Atakan N, Şimşek H: A cross-sectional study investigating association of liver diseases in moderate to severe psoriasis patients. Turkderm-Turk Arch Dermatol Venereology 2019;53:15-8
  8. Menter A, Strober BE, Kaplan DH, et al: Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with biologics. J Am Acad Dermatol 2019;80:1029-72
  9. Torres T, Bettencourt N, Mendonça D, Vasconcelos C, Silva BM, Selores M: Complement C3 as a marker of cardiometabolic risk in psoriasis. 2014;306:653-60
  10. Momose M, Asahina A, Fukuda T, Sakuma T, Umezawa Y, Nakagawa H: Evaluation of epicardial adipose tissue volume and coronary artery calcification in Japanese patients with psoriasis vulgaris. Arch Dermatol Res 2018;45:1349-52
  11. Bacaksız A, Tasal A, Sevgili E, et al: Epicardial fat thickness in patients with psoriasis vulgaris. Turk Kardiyol Dern Ars 2014;42:47-54
  12. Kamath P, Benesh G, Romanelli P, Iacobellis G: Epicardial fat: a new therapeutic target in psoriasis. Curr Pharm Des 2019;25:4914-8